Menu

Department of Military Affairs Tender by Indian Navy (GEM/2025/B/6181632)

SYNDOPA PLUS 125 MG TAB,ZOLPIDEM 5 MG TAB,CALAMINE 8 PERCENTAGE LOTION 100 ML,ALFUZOSIN 10 MG TAB,S

Goods
Qty:17.8K
Department of Military Affairs Tender by Indian Navy (GEM/2025/B/6181632)

Tender Timeline

Tender Issue
April 30, 2025 at 10:06 AM

Tender Title: Supply of Pharmaceuticals
Tender Reference Number: GEM/2025/B/6181632
Issuing Authority: Department of Military Affairs, Ministry of Defence

Scope of Work and Objectives

The objective of this tender is to procure a range of pharmaceuticals listed in the tender documentation, particularly focusing on essential medications to support the healthcare requirements of military personnel. The scope includes the supply of:

  • Syndopa Plus 125 MG Tablets (Quantity: Multiple)
  • Zolpidem 5 MG Tablets (Quantity: Multiple)
  • Calamine 8% Lotion 100 ML (Quantity: Multiple)
  • Alfuzosin 10 MG Tablets (Quantity: Multiple)
  • Sevelamer 400 MG Tablets (Quantity: Multiple)

The total quantity for all pharmaceuticals combined is 17,812 units.

Eligibility Criteria

To qualify for this tender, bidders must ensure they meet the following eligibility criteria:

  1. Registration: Bidders must be legally registered entities capable of supplying pharmaceutical products.
  2. Compliance: Bidders must comply with all applicable regulations and standards regarding pharmaceutical manufacturing and distribution.
  3. Experience: Previous experience in supplying pharmaceutical products to government or military sectors is preferred but not mandatory.

Technical Requirements

The products must meet the specified technical requirements as follows:

  • Pharmaceuticals must be registered with appropriate health authorities.
  • Each product must adhere to standard quality assurance guidelines and must be accompanied by valid certificates of analysis.

Financial Requirements

Bidders must adhere to the following financial requirements:

  • Presentation of a detailed bid price including all associated costs for the listed pharmaceuticals.
  • Submission of the Earnest Money Deposit (EMD), the amount of which is specified in the tender guidelines, must be provided alongside the bid.

Document Submission Details

All bids must include the following documentation:

  • Completed bid forms as per the outlined format.
  • Required certificates proving compliance with manufacturing standards and regulatory requirements.
  • Financial documents detailing pricing and payment terms.

Special Provisions

This tender encourages participation from Micro, Small, and Medium Enterprises (MSEs) and startups, offering provisions that may include relaxed eligibility requirements and support for development initiatives.

Evaluation Process

Bids will be evaluated on the basis of:

  1. Compliance with eligibility and technical requirements.
  2. Cost-effectiveness and overall pricing.
  3. Previous experience and performance history in similar contracts.

Delivery Locations

The pharmaceuticals procured under this tender will be delivered to military health establishments across designated locations as specified in the tender documentation.

Contact Information

For inquiries related to the tender, it is advised to consult the official website of the Department of Military Affairs or the Ministry of Defence for contact details specified in the tender communication.


Tender BOQ Items

5 Items
1.

SYNDOPA PLUS 125 MG TAB

Qty:7020
Unit:no
30
2.

ZOLPIDEM 5 MG TAB

Qty:2240
Unit:no
30
3.

CALAMINE 8 PERCENTAGE LOTION 100 ML

Qty:92
Unit:no
30
4.

ALFUZOSIN 10 MG TAB

Qty:2410
Unit:no
30
5.

SEVELAMER 400 MG TAB

Qty:6050
Unit:no
30

General Information

Item Category
SYNDOPA PLUS 125 MG TAB , ZOLPIDEM 5 MG TAB , CALAMINE 8 PERCENTAGE LOTION 100 ML , ALFUZOSIN 10 MG TAB , SEVELAMER 400 MG TAB
Ministry Name
Organisation Name
City

Financial Information

OEM Average Turnover
₹4.00 Lakh (s)
Minimum Turnover
₹1.00 Lakh (s)
Bid Offer Validity
120 (Days)
Past Performance
20 %
Arbitration Clause
No
Mediation Clause
No

Evaluation and Technical Information

Evaluation Method
Item wise evaluation/
RA Qualification Rule
H1-Highest Priced Bid Elimination
Inspection Required
Yes
Technical Clarifications Time
3 Days

Tender Documents

4 Documents
GeM-Bidding-7785824.pdfMain Document
BOQ DocumentBOQ BOQ
BOQ DocumentBOQ BOQ
GEM General Terms and Conditions DocumentGEM_GENERAL_TERMS_AND_CONDITIONS

Documents Required from Seller

  • Experience Criteria
  • Past Performance
  • Bidder Turnover
  • OEM Authorization Certificate
  • OEM Annual Turnover
  • Compliance of BoQ specification and supporting document *In case any bidder is seeking exemption from Experience / Turnover Criteria
  • the supporting documents to prove his eligibility for exemption must be uploaded for evaluation by the buyer

Similar Tenders

View All

D IFA RE 24 Cycloserine 250 mg Cap,D IFA RE 24 Fluticasone propionate lotion 0 DOT 05 bott of 10 ml

₹6.00
GEM
Goods
Qty:19.3K
6 Files
Indian Army
Boq › Boql
D IFA RE 24 Cycloserine 250 mg Cap , D IFA RE 24 Fluticasone propionate lotion 0 DOT 05 bott of 10 ml , D IFA RE 24 Fluticasone propionate inhaler for paed use 50mcg dose 120 metered doses , D IFA RE 24 Fluticasone Propionate Inhaler for Adults 125 mcg dose , D IFA RE 24 Salmeterol 50 mcg plus Fluticasone 250 mcg multi dose dry powder inhaler of 60 doses , D IFA RE 24 Salmeterol Rotacap 50mcg , D IFA RE 24 Theophylline SR 400 mg Tab , D IFA RE 24 Fexofenadine Hydrochloride Tab 120 mg , D IFA RE 24 Glucosamine 250 mg plus Chondroitin Sulphate 200 mg Cap , D IFA RE 24 Immunoglobulin Intravenous 2 DOT 5 gm Inj , D IFA RE 24 Ibuprofen Gel tube of 20 gm , D IFA RE 24 Leflunomide 20 mg Tab , D IFA RE 24 Naproxen gel tube of 20 gm , D IFA RE 24 Nimesulide gel tube of 20 gm , D IFA RE 24 Amoxycillin oral susp containing Amoxycillin base 125 mg per 5 ml after reconstitution bottle of 30 ml , D IFA RE 24 Amikacin Sulphate 250 mg 2 ml Inj , D IFA RE 24 Norfloxacin 400 mg Tab , D IFA RE 24 Ofloxacin 200 mg Tab , D IFA RE 24 Sulphamethoxazole 200 mg and Trimethoprim 40 mg per 5 ml bottle of 50 60 ml suspension , D IFA RE 24 Sulphamethoxazole 400 mg and Trimethoprim 80 mg Tab , D IFA RE 24 Acyclovir 250 mg Inj , D IFA RE 24 Acyclovir Syp 400 mg 5 ml , D IFA RE 24 Linezolid 2 mg ml 300 ml Inj , D IFA RE 24 Oseltamivir 75 mg Cap , D IFA RE 24 Brimonidine 0 DOT 2 and Brinzolamide 1 Eye Drop Bott of 5ml , D IFA RE 24 Nepafenac mocronised suspension 0 DOT 1 BAK free in 5 ml bottle , D IFA RE 24 Nitroglycerine Glyceryltrinitrate 5mg Inj , D IFA RE 24 Iron Syp Pediatric Each 5 ml Containing elemental iron of 50 mg as iron polymaltose complex in 200 ml bottle , D IFA RE 24 Methotrexate 15mg Tab , D IFA RE 24 Paroxetine 25mg Tab , D IFA RE 24 Baclofen XL 30 mg Tab , D IFA RE 24 Clozapine 50 mg Tab , D IFA RE 24 Thiamine 100mg ml Inj 2ml Amp , D IFA RE 24 MDI spacer with mask and fish mouth valve for pediatrics set , D IFA RE 24 Fluticasone Propionate and Formoterol 120 MDI , D IFA RE 24 Cabergoline 0 DOT 25mg Tab , D IFA RE 24 Misoprostol 600mcg Tab , D IFA RE 24 Diclofenac 75mg ml Inj 1ml Amp for IV bolus , D IFA RE 24 Silicone Ring Vaginal Pessary , D IFA RE 24 Cell Culture Rabies Vaccine vial of 1 ml , D IFA RE 24 Test Mantoux Sufficent for 10 tests , D IFA RE 24 Airway long transparent Oropharyngeal set consisting of size Length 000 3 DOT 5 00 5 DOT 0 0 5 DOT 0 1 7 DOT 0 2 9 DOT 0 3 10 DOT 0 4 1 DOT 0 , D IFA RE 24 Adhesive Incise drape 50 x 45 cm , D IFA RE 24 Apparatus Anaesthetic facemask with air cushion transparent size 0 infant , D IFA RE 24 Apparatus Anaesthetic facemask with air cushion transparent size 1 paediatric , D IFA RE 24 Apparatus Anaesthetic facemask Antistatic with air cushion transparent size 3 adult with valve , D IFA RE 24 Apparatus Anaesthetic facemask Antistatic with air cushion transparent size 4
April 30, 2025
May 22, 2025 at 10:00 AM
View Details

D IFA22 Caffeine Citrate 20 mgml Inj 1ml vial,D IFA22 Salmeterol 25 mcg plus Fluticasone 125 mg MDI

GEM
Goods
Qty:26.4K
6 Files
Indian Army
Boq › Boql
D IFA22 Caffeine Citrate 20 mgml Inj 1ml vial , D IFA22 Salmeterol 25 mcg plus Fluticasone 125 mg MDI 120 doses , D IFA22 Caffeine Citrate 20mgml Oral Solution 1ml Syp , D IFA22 Fluconazole 10 mgml 30 ml Syp , D IFA22 Linezolid dry powder 100mg30ml , D IFA22 Frusemide 10 mgml 30 ml Syp , D IFA22 Domperidone Syp 1 mgml bott of 30 ml , D IFA22 Dicyclomine drops of 15 ml , D IFA22 Norflox Syp 100mg5ml bott of 30 ml , D IFA22 Phenobarbitone Syp 20 mg5 ml bott of 60 ml , D IFA22 Prednisolone Syp 5mg5ml in bott of 30 ml , D IFA22 Roxithromycin 50mg5ml Syp in bott of 30 ml , D IFA22 Natural Surfactant 25 to 80mgml Inj , D IFA22 Triclofos Syp 500 mg5ml in 30ml bottle , D IFA22 Human Milk fortifier 2 gm sachet , D IFA22 Calcium Phosphate 80 mg5 ml Syp 200ml bott , D IFA22 Bupropion HCl 150 mg SR Tab , D IFA22 Buspirone HCl 10 mg Tab , D IFA22 Clonazepam 0dot5 mg Tab , D IFA22 Clomipramine HCl 25 mg Tab , D IFA22 Doxepin HCl 75 mg Cap , D IFA22 Fluoxetine HCl 20 mg Cap , D IFA22 Haloperidol decanoate 50 mgml Inj in 1ml amp , D IFA22 Imipramine 25 mg Tab , D IFA22 Lithium Carbonate 300 mg CapTab , D IFA22 Memantine 5 mg Tab , D IFA22 Aripiprazole 10 mg Tab , D IFA22 Zolpidem 10 mg Tab , D IFA22 Quetiapine 50 mg Tab , D IFA22 Paroxetine XR 12dot5 Tab , D IFA22 Amisulpride 200mg Tab , D IFA22 Theophylline anhydrous syrup 60 mg in 5 ml as 100ml bottledot , D IFA22 Beclomethasone Dipropionate 50 mcg and Levosalbutamol 50 mcg per metred dose in CFC free MDI , D IFA22 Salmeterol 50 mcg plus Fluticasone 500 mcg Accuhaler , D IFA22 Cough Syrup Each 5 ml contains Chlorpheniramine Maleate IP 3 mg Ammonium Chloride IP 110 mg Sodium Citrate IP 46 mg Menthol IP 0dot9 mg Bott of 110 ml , D IFA22 Cough expectorant syp 5 ml containingDiphenhydramine HCl 14dot08mg AmmoniumChloride 0dot138 gm Sodium Citrate 57dot03mg Menthol 1dot14 mg in flavoured syp basebott of 100 110 ml , D IFA22 Codeine Phosphate 10 mg plus Chlorpheniramine Maleate 4 mg per 5 ml Syp bottle of 100 ml , D IFA22 Disodium Hydrogen Citrate Syp Bott of 100ml , D IFA22 Antimicrobial Hand Gel Containing Ethyl Alcohol 60prcntge plus Cyclomethicone C1215 Alkyl Lactate plus Cetyl Lactate plus Phenoxyethanol plus Stearyl Alcohol with moisturizer , D IFA22 Anti phlebitis cream Tube of 15 g20 g , D IFA22 Haemostatic sponge gelatin 80 mm long 50mm broad 10 mm thick , D IFA22 Desmopressin Nasal spray 0dot1 mgml in vial of 2dot5 ml , D IFA22 Vit B1 50 mg Inj , D IFA22 Vitamin A solution IP 50 ml , D IFA22 Calcium 9 mg plus Calcium gluconate 50 mg Inj for IV use 10 ml Injection , D IFA22 Iron Syp Paediatric each 5 ml containing elemental Iron 2550 mg and Folic Acid 500 mcg bottle of 200 ml , D IFA22 Multi Vit Inj IV 210 ml with minimum constituents having Thiamine B130mgml Pyridoxine B6 30mgml and B12 Cyanocobalamin300 mcgml , D IFA22 Niacin 500mg Tab , D IFA22 Drop VitaminD3 Cholecalciferol 200 IUml , D IFA22 Dapagliflozin 5 mg plus Metformin 1000 mg IR Tab
April 30, 2025
May 22, 2025 at 10:00 AM
View Details

Aceclofenac 100 mg Paracetamol 500 mg Tab,Paracetamol 325 mg plus Diclofenac Sodium 50 mg Tab,Diclo

₹71.00
GEM
Goods
Qty:1.2L
4 Files
Indian Army
WEST KAMENG, ARUNACHAL PRADESH
Boq › Boql
Aceclofenac 100 mg Paracetamol 500 mg Tab , Paracetamol 325 mg plus Diclofenac Sodium 50 mg Tab , Diclofenac Sodium SR 100 mg Tab , Paracetamol Suppository 80 mg , Naproxen 250mg Tab , Etoricoxib 120 mg Tab , Piroxicam 20 mg Tab , Tramadol HCl 50 mg Cap oblic Tab , Cetirizine- Dihydrochloride 10 mg Tab , Levo-Cetirizine 5mg Tab , Dexamethasone 0 point 5 mg oblic Tab , Pheniramine Maleate 25 mg Tab , Prednisolone 5 mg Tab , Sodium valporate 200 mg plus Valporic Acid 87 mg Tab , Oxcarbazepine 300 mg Tab , Carbamazepine 200 mg Tab , Gabapentin 300 mg Cap , Sodium Valproate 200 mg Tab , Topiramate 25 mg Tab , Rizatriptan 5 mg Tab , Baclofen 10 mg Tab , Cap Saccharomyces boulardii 250 mg , Tab Acebrophylline 100 mg , Gliclazide XR 60 mg Tab , Hydrocortisone 5 mg Tab , Mycophenolate Mofetil 250 mg Tab , Ampicillin IP 250 mg Cap , Ampicillin IP 500 mg Cap , Co-trimoxazole Suphamethoxazole 100 mg Trimethoprim 20 mg Tab , Dapsone 50 mg Tab , Tab Amitriptyline 25 mg , Itopride 50 mg Tab , Rifampicin 150 mg Cap , Rifampicin 600 mg plusTab INH 300 mg Tab , Ethambutol 200 mg Tab , Tetracyclin IP 500 mg Cap , Isoniazid 100 mg with Pyridoxine 5 mg Tab , Isoniazid 300 mg Tab , Pyrazinamide 0 point 5 gm Tab , Pyrazinamide 1500 mg Tab , Ciprofloxacin 250 mg plus Tinidazole 300 mg Tab , Metronidazole 400 mg Tab , Sulphadoxine 500 mg and Pyrimethamine 25 mg Tab , Mycophenolate mofetil 500mg Tab , Methotrexate 2 point 5mg Tab , Letrozole 2 point 5 mg Tab , Tab Methylcobalamine 1500 mcg , Acenocoumarol 4 mg Tab , Acenocoumarol 1 mg Tab , Tranexamic Acid 500mg Tab , Fenofibrate 160mg Tab , Carvedilol 3 point 125mg Tab , Tab Ticagrelor 90 mg , Diltiazem 60 mg Tab , Fenofibrate 200 mg Tab , Tab Dabigatran Etexilate 110mg , Torsemide 10 mg Scored Tab , Nitroglycerin 5 mg Controlled Release Patches , Tab Dabigatran Etexilate 150mg , Amiodarone HCl 200 mg Tab , Rosuvastatin 5 mg Tab , Enalapril Maleate 10 mg Tab , Enalapril Maleate 2 point 5 mg Tab , Propranolol TR 40 mg Tab , T Propanolol 20mg , Ramipiril 2 point 5 mg Tab , Tab Ivabradine 5 mg , Digoxin 0 point 25 mg Tab , Tab Sacubitril 24 mg plus Valsartan 26 mg , Tab Metoprolol XL 25 mg , Aspirin 75 mg Tab , Tab Telmisartan 40 mg Amlodipine 10 mg plus Hydrochlorothiazide 12 point 5mg , Metoprolol Extended release 50mg , Atenolol 50mg plus Amlodipine 5 mg Tab , Hydrochlorothiazide 25mg , Telmisartan 40 mg Tab , Indapamide SR 1 point 5 mg Tab , Losartan 25 mg Tab , Ramipril 10 mg Tab , Tab Enalapril 5 mg , Telmisartan 40 mg plus Hydrochlorothiazide 12 point 5 mg Tab , Metoprolol 12 point 5 mg Tab , Propranolol 20 mg Tab , Acetazolamide 0 point 25g Tab , Tab Dutasteride 0 point 5 mg , Cilnidipine 5 mg Tab , Frusemide 40 mg Tab , Torsemide 20 mg , Ursodeoxycholic Acid 150mg Tab , Pancreatic Enzyme supplement with a Lipase content of 25000 units or more Cap , Tab Ademetionine 400 mg , Ranitidine 150 mg Tab , Lactic Acid Bacillus Sachet , Domperidone 10 mg Tab
April 30, 2025
May 21, 2025 at 2:00 PM
View Details

Frequently Asked Questions

The eligibility requirements include being a registered entity capable of supplying pharmaceuticals. Bidders must demonstrate compliance with applicable pharmaceutical regulations and standards. Preference may be given to entities with prior experience in supplying to government or military sectors.

Bidders are required to provide valid certificates that verify compliance with manufacturing standards and health regulations. This includes certificates of analysis for each pharmaceutical product and any relevant regulatory approvals.

To engage in the tender process, bidders must complete the registration on the GEM platform. This involves providing company details, uploading necessary documents, and ensuring compliance with the eligibility criteria to qualify for submission.

Bidders must submit an EMD alongside their bid, the exact amount of which will be specified in the tender documentation. The EMD ensures the seriousness of the bid and acts as a deposit that may be refunded upon completion of the evaluation process.

The tender offers special provisions aimed at promoting Micro, Small, and Medium Enterprises (MSEs). This includes easier eligibility criteria and potential financial relief or benefits to encourage their participation in government tenders, aligning with governmental initiatives to support small businesses.

Probable Bidders

Companies likely to bid

Get Tender Alerts

Get notifications for similar tenders